Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | NOC | Common Stock | 1.63K | Jan 1, 2022 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | NOC | Restricted Stock Rights | Jan 1, 2022 | Common Stock | 968 | Direct | F1, F2 | |||||||
holding | NOC | Restricted Performance Stock Rights | Jan 1, 2022 | Common Stock | 2.21K | Direct | F3, F4 |
Id | Content |
---|---|
F1 | Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. |
F2 | Total amount includes (i) 328 unvested RSRs granted under the LTISP on 2/13/19 that will vest on 2/14/22; (ii) 284 unvested RSRs granted under the LTISP on 2/12/20 that will vest on 2/13/23; and (iii) 356 unvested RSRs that will vest on 2/16/24. Grants awarded pursuant to Rule 16b-3(d). |
F3 | Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). |
F4 | Total amount includes (i) 766 unvested RPSRs granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 2/13/19 with a measurement period ended on 12/31/21; (ii) 663 unvested RPSRs granted under the LTISP on 2/12/20 with a measurement period ending on 12/31/22; and (iii) 783 unvested RPSRs granted under the LTISP on 2/16/21 with a measurement period ending on 12/31/23. Grants awarded pursuant to Rule 16b-3(d). |